Mutations in the SF3B1 gene, represents a subset of MDS with favourable prognosis, results in reprogramming of mitochondrial metabolism related to decreased cellular respiration capacity in a process mediated by the mis-splicing of and downregulation of UQCC114. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.